Experiences with various types of mitral valve prostheses

Area of Science:

• Cardiovascular Surgery
• Biomedical Engineering
• Clinical Trials

Background:

• Mitral valve replacement is a critical procedure in managing severe mitral valve disease.
• The choice of prosthetic valve can significantly impact patient outcomes, including mortality, thromboembolic events, and functional status.

Purpose of the Study:

• To compare the clinical performance of four different types of mitral valve prostheses.
• To evaluate mortality rates, thromboembolic complications, functional class improvement, and hemodynamic performance (diastolic gradients) across the prostheses.

Main Methods:

• A retrospective study involving 139 patients who underwent mitral valve replacement between 1967 and 1973.
• Four distinct mitral valve prostheses were implanted by the same surgical group using consistent operative techniques.
• Patients received adequate anticoagulant therapy; outcomes were assessed at follow-up.

Main Results:

• Total mortality ranged from 17% (Björk-Shiley) to 40% (Beall).
• Thrombo-embolic complications led to deaths in the Beall and Lillehei-Nakib groups.
• Functional class improved in 40-77% of patients, with the Björk-Shiley group showing the best improvement.
• The Björk-Shiley valve demonstrated the most favorable hemodynamic profile with the lowest diastolic gradients (4 mmHg at rest).

Conclusions:

• The Björk-Shiley mitral valve prosthesis exhibited superior performance regarding lower mortality, reduced thromboembolic complications, enhanced functional recovery, and favorable hemodynamics.
• These findings highlight the importance of prosthesis selection in optimizing outcomes for mitral valve replacement surgery.